Primary Site >> Stomach Cancer
Gene >> PROM1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Transcription starting from an alternative promoter leads to the expression of the human ABO histo-blood group antigen. PMID: 12702190 |
Ref: [Purification, identification and oriented differentiation of endothelial progenitor cells from human umbilical cord blood]. PMID: 17283881 |
Ref: Comparative genomics on PROM1 gene encoding stem cell marker CD133. PMID: 17487431 |
Ref: CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. PMID: 18542072 |
Ref: Identification of gastric cancer stem cells using the cell surface marker CD44. PMID: 19415765 Ref: mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. PMID: 19738050 |
Ref: Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients. PMID: 19619937 Ref: Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors. PMID: 20043076 Ref: Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. PMID: 20487522 Ref: Demethylation of the CD133 gene is frequently detected in early gastric carcinoma. PMID: 20530428 Ref: Prognostic impact of CD133 expression in gastric carcinoma. PMID: 20651407 |
Ref: Omental milky spots in screening gastric cancer stem cells. PMID: 21067262 Ref: Phenotypic heterogeneity of breast cancer stem cells. PMID: 21317983 Ref: Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PMID: 21394208 Ref: Genotypic and phenotypic characterization of side population of gastric cancer cell lines. PMID: 21435459 Ref: CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation. PMID: 21457403 Ref: Current molecular markers for gastric progenitor cells and gastric cancer stem cells. PMID: 21626457 Ref: Sequential expression of putative stem cell markers in gastric carcinogenesis. PMID: 21829201 Ref: Gastric cancer: basic aspects. PMID: 21896084 |
Ref: Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. PMID: 21523522 Ref: CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. PMID: 21898409 Ref: Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. PMID: 22243781 Ref: [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties]. PMID: 22368028 Ref: Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer. PMID: 22395309 Ref: CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer. PMID: 22674531 Ref: Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. PMID: 22688186 |
Ref: Expression patterns of Thymosin beta4 and cancer stem cell marker CD133 in ovarian cancers. PMID: 23055022 Ref: Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. PMID: 23440340 Ref: Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PMID: 23533603 Ref: Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. PMID: 23609373 Ref: Primo vascular system and its potential role in cancer metastasis. PMID: 23852507 Ref: Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis. PMID: 23874550 Ref: [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition]. PMID: 23888452 Ref: [Effect of RNA interference inhibition to expression of CD133 on tumor cell biological characteristics in KATO-III CD133(+) cells of human gastric cancer]. PMID: 24062002 |
Ref: Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. PMID: 23558457 Ref: RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. PMID: 23881612 Ref: Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience. PMID: 24521695 Ref: [Relationship between CD133 and chemoresistance in human gastric cancer and its associated mechanism]. PMID: 24577774 Ref: Distribution of endothelial progenitor cells in tissues from patients with gastric cancer. PMID: 24765203 Ref: Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. PMID: 24833872 Ref: Study on the Biological Characteristics of CD133 (+) Cells Interfered by RNA Interference in Gastric Cancer. PMID: 25006468 Ref: Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion. PMID: 25174257 Ref: Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells. PMID: 25230779 Ref: Prognostic significance of expression of CD133 and Ki-67 in gastric cancer. PMID: 25339008 |
Ref: Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer. PMID: 24302553 Ref: Stem cells in gastric cancer. PMID: 25574084 Ref: [Experimental study of human bone marrow mesenchymal stem cells on regulating the biological characteristics of gastric cancer cells]. PMID: 25656126 Ref: Prognostic value of circulating CD133(+) cells in patients with gastric cancer. PMID: 25727099 Ref: A preliminary study of side population cells in human gastric cancer cell line HGC-27. PMID: 25773762 Ref: Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry. PMID: 26028069 Ref: Myeloid cell leukemia-1 promotes epithelial-mesenchymal transition of human gastric cancer cells. PMID: 26058661 Ref: Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness. PMID: 26498753 Ref: CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis. PMID: 26503471 |
Ref: Reduced proliferation and increased apoptosis of the SGC7901 gastric cancer cell line on exposure to GDC0449. PMID: 26676867 Ref: Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. PMID: 26769843 Ref: The roles of serum PDCD5 in circulating CD133 positive cells of the patients with gastric cancer. PMID: 27034262 Ref: Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. PMID: 27079437 Ref: AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy. PMID: 27144437 Ref: 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells. PMID: 27279287 Ref: Notch1 directly induced CD133 expression in human diffuse type gastric cancers. PMID: 27489358 Ref: Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study. PMID: 27557490 Ref: Long Noncoding RNA ROR Regulates Proliferation, Invasion, and Stemness of Gastric Cancer Stem Cell. PMID: 27602437 Ref: Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. PMID: 27619680 Ref: Cancer stem cell marker CD90 inhibits ovarian cancer formation via beta3 integrin. PMID: 27633757 Ref: Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved. PMID: 27759647 Ref: Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood. PMID: 27779706 |
Ref: DKK3 attenuates the cytotoxic effect of natural killer cells on CD133(+) gastric cancer cells. PMID: 28218426 Ref: Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer. PMID: 28326835 Ref: Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells. PMID: 28352350 Ref: Isolation of cancer progenitor cells from cancer stem cells in gastric cancer. PMID: 28393208 Ref: USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein. PMID: 28415621 Ref: Predictive value for lymph node metastasis of epithelial-mesenchymal transition and cancer stem cell marker expression in early gastric cancer. PMID: 28595915 Ref: miR-200b inhibits CD133(+) glioma cells by targeting the AKT pathway. PMID: 28599471 Ref: Personalizing Gastric Cancer Screening With Predictive Modeling of Disease Progression Biomarkers. PMID: 29084052 Ref: CD133 mediates the TGF-beta1-induced activation of the PI3K/ERK/P70S6K signaling pathway in gastric cancer cells. PMID: 29344155 |
Ref: Toward early detection of Helicobacter pylori-associated gastric cancer. PMID: 28725964 Ref: Interaction between CD133 and PI3K-p85 promotes chemoresistance in gastric cancer cells. PMID: 29423015 Ref: Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. PMID: 29796189 Ref: CD133 Expression as a Helicobacter pylori-independent Biomarker of Gastric Cancer Progression. PMID: 30061208 Ref: LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/beta-catenin pathway and predicts poor survival of glioma patients. PMID: 30208924 |